--- title: "HIMS 投資者有機會與 SBS Law 一起參與對 Hims & Hers Health, Inc.的欺詐調查" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/294401035.md" description: "Schall, Brown & Schwartz LLP 正在調查 Hims & Hers Health, Inc.（紐約證券交易所代碼：HIMS）是否存在潛在的證券法違規行為。該調查重點審查公司是否發佈了誤導性聲明或未能披露重要信息，特別是關於聯邦貿易委員會（FTC）提起的訴訟，指控其存在隱私侵犯和欺詐性收費行為。遭受損失的投資者被鼓勵聯繫該公司以討論他們的權利" datetime: "2026-07-30T18:08:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294401035.md) - [en](https://longbridge.com/en/news/294401035.md) - [zh-HK](https://longbridge.com/zh-HK/news/294401035.md) generator: "portal-rs" --- # HIMS 投資者有機會與 SBS Law 一起參與對 Hims & Hers Health, Inc.的欺詐調查 **HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law** Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“ Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of the securities laws. **INVESTIGATION DETAILS:** The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Hims & Hers is the subject of an FTC lawsuit filed on July 29, 2026. According to the FTC, the Company “shared consumers’ sensitive health information about medical conditions with third-party advertising platforms despite claiming its services maintain consumers’ privacy and deceives users about its billing and cancellation practices.” If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at david@schallfirm.com **WHY SBS?** Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. Schall, Brown & Schwartz LLP Brian Schall, Esq., Andrew Brown, Esq., David Schwartz, Esq., www.schallfirm.com Office: 310-301-3335 info@schallfirm.com View source version on businesswire.com: https://www.businesswire.com/news/home/20260730332686/en/ ### 相關股票 - [HIMS.US](https://longbridge.com/zh-HK/quote/HIMS.US.md) - [HIMY.US](https://longbridge.com/zh-HK/quote/HIMY.US.md) - [HIMZ.US](https://longbridge.com/zh-HK/quote/HIMZ.US.md) - [HIYY.US](https://longbridge.com/zh-HK/quote/HIYY.US.md) ## 相關資訊與研究 - [欺詐性減肥藥物：FDA 警告稱 GLP-1 藥物標籤錯誤](https://longbridge.com/zh-HK/news/297780500.md) - [Hims & Hers Health 通過在澳大利亞的推出擴大其國際影響力](https://longbridge.com/zh-HK/news/297625567.md) - [Hims & Hers 首席法律官 Soleil Boughton 出售了 691,808 美元的普通股](https://longbridge.com/zh-HK/news/296533249.md) - [由於減肥投訴激增，Hims & Hers Health 遭到 Visa 的處罰](https://longbridge.com/zh-HK/news/296666214.md) - [據報道，Hims & Hers Health 因信用卡爭議面臨 Visa 的處罰](https://longbridge.com/zh-HK/news/296655804.md) --- > **免責聲明: 本文僅供參考，不構成任何投資建議。**